Bromocriptine approved as the first medication to target dopamine activity to improve glycemic control in patients with type 2 diabetes

Michael A Via, Himani Chandra, Takako Araki, et al

Diabetes, Metabolic Syndrome and Obesity 2010, 3:43-48

Published Date: 26 March 2010